In this interview, Thermo Fisher Scientific discusses how to accelerate drug discovery through analytical R&D.
BridgeBio secures $1.25bn for genetic therapy development
Share this article The financing will expedite the launch of acoramidis for treating transthyretin amyloid cardiomyopathy. Credit: Olena Yakobchuk / Shutterstock.com. BridgeBio Pharma has secured